CounterAct Night Content of Label
CounterAct by
Drug Labeling and Warnings
CounterAct by is a Otc medication manufactured, distributed, or labeled by Melaleuca, Inc.. Drug facts, warnings, and ingredients follow.
Drug Details [pdf]
COUNTERACT NIGHT- acetaminophen, diphenydramine hci, phenylephrine hci tablet, coated
Melaleuca, Inc.
Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.
----------
CounterAct Night Content of Label
Active Ingredients (in each caplet)
Acetaminophen 325 mg
Diphenhydramine HCI 25 mg
Phenylephrine HCI 5 mg
Uses
- temporarily relieves these symptoms of hay fever and the common cold:
-
- runny nose
- nasal congestion
- headache
- sinus pressure and congestion
- sore throat
- minor aches and pains
- sneezing
- temporarily relieves these additional symptoms of hay fever:
-
- itching of the nose or throat
- itchy, watery eyes
- temporarily reduces fever
Warnings Liver warning:
This product contains acetaminophen. Severe liver damage may occur if you take:
- more than 12 caplets in 24 hours, which is the maximum daily amount
- with other drugs containing acetaminophen
- 3 or more alcoholic drinks every day while using this product
Sore throat warning: If sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, nausea, or vomiting, consult a doctor promptly.
Do not use
- with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.
- with any other product containing diphenhydramine, even one used on skin
- if you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, phychiatric or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains an MAOI, ask a doctor or pharmacist before taking this product.
- if you have ever had an allergic reaction to this product or any of its ingredients
Ask a doctor before use if you have
- heart disease
- liver disease
- high blood pressure
- diabetes
- thyroid disease
- glaucoma
- trouble urinating due to an enlarged prostate gland
- a breathing problem such as emphysema or chronic bronchitis
Ask a doctor or pharmacist before use if you are
- taking the blood thinning drug warfarin
- taking sedatives or tranquilizers
When using this product
- do not exceed recommended dosage
- excitability may occur, especially in children
- marked drowsiness may occur
- avoid alcoholic drinks
- alcohol, sedatives, and tranquilizers may increase drowsiness
- use caution when driving a motor vehicle or operating machinery
Stop use and ask a doctor if
- nervousness, dizziness, or sleeplessness occur
- pain or nasal congestion gets worse or lasts more than 7 days
- fever gets worse or lasts more than 3 days redness or swelling is present new symptoms occur
These could be signs of a serious condition.
Overdose warning: Taking more than the recommended dose (overdose) may cause liver damage. In case of overdose, get medical help or contact a Poison Control Center right away. Quick medical attention is critical for adults as well as for children even if you do not notice any signs or symptoms.
Directions
do not use more than directed (see overdose warning) adults and children 12 years and over
-
- take 2 caplets every 4 hours
- do not take more than 12 caplets in 24 hours
-
children under 12 years: do not use this adult product in children under 12 years of age; this will provide more than the recommended dose (overdose) and may cause liver damage
Inactive ingredients corscarmellose sodium, crospovidone, FD and C No. 1, hydroxypropyl cellulose, hypromellose, magnesium stearate, microcrystalline cellulose, povidone, polyethylene glycol, pregelatinized starch, silicon dioxide, stearic acid, titanium dioxide
| COUNTERACT
NIGHT
acetaminophen, diphenydramine hci, phenylephrine hci tablet, coated |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Labeler - Melaleuca, Inc. (139760102) |